Is a complete EVMN research report available?

No complete published report is available for Evommune, Inc. (EVMN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Evommune, Inc. (EVMN)

NYSE: EVMN · USD

$6.25

+1.09 (+21.0%)· Recorded snapshot

Market cap	226.6M
Revenue (ttm)	10M
Net income (ttm)	-94.7M
EPS (ttm)	-$4.15
Shares out	36.3M
Volume	6,372,781

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10M
Net income (ttm): -94.7M
EPS (ttm): -$4.15
Market cap: 226.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Metric	Value
Amount currency	USD
CIK code	0002044725
Company name	Evommune, Inc.
Country	United States
Country code	US
CUSIP number	30054Y107
Earnings date	2026-11-11
Earnings time	amc
Employees	48
Enterprise value	$34.5M
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2020
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2025-11-06
Is primary listing	Yes
Is SPAC	No
ISIN number	US30054Y1073
Last 10-K release date	2026-03-05
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$226.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$6.25
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	EVMN
Tags	pharmaceuticals
U.S. state	California
Website	https://www.evommune.com

Metric

Value

Amount currency

USD

CIK code

0002044725

Company name

Evommune, Inc.

Country

United States

Country code

CUSIP number

30054Y107

Earnings date

2026-11-11

Earnings time

amc

Employees

Enterprise value

$34.5M

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2020

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2025-11-06

Is primary listing

Yes

Is SPAC

ISIN number

US30054Y1073

Last 10-K release date

2026-03-05

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$226.6M

Market cap category

Micro-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$6.25

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

EVMN

Tags

pharmaceuticals

U.S. state

California

Website

https://www.evommune.com

Metric	Value
Earnings yield	-66.42%
EV/Sales	4.23x
FCF / EV yield	-176.56%
FCF yield	-31.84%
P/B ratio	0.67x
P/S ratio	23.44x
Price / tangible book value	0.84x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-66.42%

EV/Sales

4.23x

FCF / EV yield

-176.56%

FCF yield

-31.84%

P/B ratio

0.67x

P/S ratio

23.44x

Price / tangible book value

0.84x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	100%
Operating margin	-1,018.94%
Pretax margin	-946.68%
Profit per employee	$-2M
Revenue per employee	$208,333
ROA	-31.99%
ROCE	-35.82%
ROE	-52.11%
ROIC	-34.17%
SBC / revenue	128.08%

Metric

Value

Gross margin

100%

Operating margin

-1,018.94%

Pretax margin

-946.68%

Profit per employee

$-2M

Revenue per employee

$208,333

ROA

-31.99%

ROCE

-35.82%

ROE

-52.11%

ROIC

-34.17%

SBC / revenue

128.08%

Metric	Value
EPS growth quarters	4
EPS growth years	1
Gross profit growth	233.33%
Net income growth years	0
Revenue growth	233.33%
Revenue growth years	2

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

233.33%

Net income growth years

Revenue growth

233.33%

Revenue growth years

Metric	Value
Capital expenditures	$-501,000
Depreciation and amortization	$1.5M
EBIT	$-101.9M
EBITDA	$-100.4M
EPS	$-4.15
FCF per share	$-2.06
Financing cash flow	$274.2M
Free cash flow	$-74.7M
Free cash flow minus SBC	$-87.5M
Gross profit	$10M
Investing cash flow	$-200.9M
Net borrowing	$-451,000
Net cash flow	$-808,000
Net income	$-94.7M
Operating cash flow minus SBC	$-87M
Operating income	$-101.9M
Revenue	$10M
Stock-based compensation	$12.8M

Metric

Value

Capital expenditures

$-501,000

Depreciation and amortization

$1.5M

EBIT

$-101.9M

EBITDA

$-100.4M

EPS

$-4.15

FCF per share

$-2.06

Financing cash flow

$274.2M

Free cash flow

$-74.7M

Free cash flow minus SBC

$-87.5M

Gross profit

$10M

Investing cash flow

$-200.9M

Net borrowing

$-451,000

Net cash flow

$-808,000

Net income

$-94.7M

Operating cash flow minus SBC

$-87M

Operating income

$-101.9M

Revenue

$10M

Stock-based compensation

$12.8M

Metric	Value
Altman Z-Score	16.62
Book value per share	$7.65
Debt / equity	0.03
Long-term assets	$97.7M
Long-term liabilities	$6.9M
Net cash (debt)	$192.2M
Net cash / market cap	81.96%
Net cash growth	123.38%
Net debt / equity	-0.69
Piotroski F-Score	2
Property, plant and equipment	$9.2M
Shareholders' equity	$277.6M
Tangible book value	$277.6M
Tangible book value per share	$7.65
Total assets	$301.9M
Total cash	$200.8M
Total debt	$8.6M
Total liabilities	$24.4M

Metric

Value

Altman Z-Score

16.62

Book value per share

$7.65

Debt / equity

0.03

Long-term assets

$97.7M

Long-term liabilities

$6.9M

Net cash (debt)

$192.2M

Net cash / market cap

81.96%

Net cash growth

123.38%

Net debt / equity

-0.69

Piotroski F-Score

Property, plant and equipment

$9.2M

Shareholders' equity

$277.6M

Tangible book value

$277.6M

Tangible book value per share

$7.65

Total assets

$301.9M

Total cash

$200.8M

Total debt

$8.6M

Total liabilities

$24.4M

Metric	Value
Asset turnover	0.05
Current assets	$204.2M
Current liabilities	$17.5M
Current ratio	11.68
Net working capital	$-12.3M
Quick ratio	11.48
Working capital	$186.8M
Working capital turnover	0.07

Metric

Value

Asset turnover

0.05

Current assets

$204.2M

Current liabilities

$17.5M

Current ratio

11.68

Net working capital

$-12.3M

Quick ratio

11.48

Working capital

$186.8M

Working capital turnover

0.07

Metric	Value
Buyback yield / dilution	-1,390.45%
Dividend yield	0%
Shareholder yield	-1,390.45%

Metric

Value

Buyback yield / dilution

-1,390.45%

Dividend yield

Shareholder yield

-1,390.45%

Metric	Value
150-day SMA	$16.11
1D price change	21.03%
1M price change	-26.86%
1M total return	-26.86%
1W price change	15.43%
1W total return	15.43%
20-day SMA	$5.89
200-day SMA	$17.90
3M price change	-45.86%
3M total return	-45.86%
50-day SMA	$9.09
50-day SMA vs 200-day SMA	50under200
52-week high	$33.20
52-week high date	2026-02-10
52-week low	$4.94
52-week low date	2026-10-23
6M price change	-75.16%
6M total return	-75.16%
All-time high	$33.20
All-time high date	2026-02-10
All-time low	$4.94
All-time low date	2026-10-23
Average true range (ATR)	$0.57
Average volume	1.1M
Beta (1Y)	0.81
Change from 52-week high	-81.19%
Change from 52-week low	26.42%
Change from all-time high	-81.3%
Change from all-time low	25.71%
Change from open	13.55%
Day's gap	6.59%
Dollar volume	$39.8M
High price	$7.20
Low price	$5.42
Monthly RSI	0
Open price	$5.50
Position in 52-week range	46.35%
Premarket change	6.59%
Premarket close	$5.16
Premarket price	$5.50
Premarket volume	9.1K
Previous close	$5.16
Price vs 150-day SMA	-61.45%
Price vs 20-day SMA	5.52%
Price vs 200-day SMA	-65.31%
Price vs 50-day SMA	-31.67%
Relative volume	5.86
Return from IPO open	-62.55%
Return from IPO price	-59.63%
RSI	42.49
Sharpe ratio	-0.49
Sortino ratio	-0.73
Volume	6.4M
Weekly RSI	35.95
YTD price change	-63.73%
YTD total return	-63.73%

Metric

Value

150-day SMA

$16.11

1D price change

21.03%

1M price change

-26.86%

1M total return

-26.86%

1W price change

15.43%

1W total return

15.43%

20-day SMA

$5.89

200-day SMA

$17.90

3M price change

-45.86%

3M total return

-45.86%

50-day SMA

$9.09

50-day SMA vs 200-day SMA

50under200

52-week high

$33.20

52-week high date

2026-02-10

52-week low

$4.94

52-week low date

2026-10-23

6M price change

-75.16%

6M total return

-75.16%

All-time high

$33.20

All-time high date

2026-02-10

All-time low

$4.94

All-time low date

2026-10-23

Average true range (ATR)

$0.57

Average volume

1.1M

Beta (1Y)

0.81

Change from 52-week high

-81.19%

Change from 52-week low

26.42%

Change from all-time high

-81.3%

Change from all-time low

25.71%

Change from open

13.55%

Day's gap

6.59%

Dollar volume

$39.8M

High price

$7.20

Low price

$5.42

Monthly RSI

Open price

$5.50

Position in 52-week range

46.35%

Premarket change

6.59%

Premarket close

$5.16

Premarket price

$5.50

Premarket volume

9.1K

Previous close

$5.16

Price vs 150-day SMA

-61.45%

Price vs 20-day SMA

5.52%

Price vs 200-day SMA

-65.31%

Price vs 50-day SMA

-31.67%

Relative volume

5.86

Return from IPO open

-62.55%

Return from IPO price

-59.63%

RSI

42.49

Sharpe ratio

-0.49

Sortino ratio

-0.73

Volume

6.4M

Weekly RSI

35.95

YTD price change

-63.73%

YTD total return

-63.73%

Metric	Value
Float	19.9M
Float percentage	54.78%
Shares change (QoQ)	7.32%
Shares change (YoY)	1,390.45%
Shares held by insiders	2.5%
Shares held by institutions	61.34%
Shares outstanding	36.3M
Short % of float	14.55%
Short % of shares	7.97%
Short ratio	3.6 days

Metric

Value

Float

19.9M

Float percentage

54.78%

Shares change (QoQ)

7.32%

Shares change (YoY)

1,390.45%

Shares held by insiders

2.5%

Shares held by institutions

61.34%

Shares outstanding

36.3M

Short % of float

14.55%

Short % of shares

7.97%

Short ratio

3.6 days

Metric	Value
Page views	243

Metric

Value

Page views

243

Evommune, Inc. (EVMN)

Price

Financial snapshot

Fair-value bridge

Latest news · EVMN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EVMN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on EVMN

Frequently asked questions